Trial Profile
Multi-centre, oral single dose experimental and modelling study to evaluate the pharmacokinetics of deferiprone in patients aged from 1 month to less than 6 years of age affected by transfusion-dependent haemoglobinopathies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary)
- Indications Iron overload
- Focus Pharmacokinetics
- Acronyms DEEP-1
- 19 Sep 2016 Results Results assessing population pharmacokinetics and dosing recommendations published in the British Journal of Clinical Pharmacology
- 21 Jun 2014 Status changed from recruiting to completed, as per European Clinical Trials Database record.
- 10 Mar 2014 New trial record